- Condition: Alzheimer's Disease
Interventions: Drug: LY2886721; Drug: Placebo
Sponsors: Eli Lilly and Company; Eli Lilly and Company
Recruiting - verified May 2012 - Condition: Alzheimer's Disease
Interventions: Drug: ABT-126; Drug: ABT-126; Drug: placebo
Sponsors: Abbott; Abbott
Recruiting - verified March 2012 - Condition: Alzheimer´s Disease
Interventions: Biological: Immune Globulin Intravenous (Human), 10% Solution; Biological: Human albumin 0.25%
Sponsors: Baxter Healthcare Corporation; Baxter Healthcare Corporation
Recruiting - verified May 2012 - Condition: Alzheimer's Disease
Interventions: Drug: Resveratrol; Drug: Placebo
Sponsors: Alzheimer's Disease Cooperative Study (ADCS); Alzheimer's Disease Cooperative Study (ADCS); National Institute on Aging (NIA)
Recruiting - verified May 2012 - Condition: Alzheimer's Disease
Interventions: Drug: BMS-241027; Drug: BMS-241027; Drug: BMS-241027; Drug: Placebo matching BMS-241027
Sponsors: Bristol-Myers Squibb; Bristol-Myers Squibb
Recruiting - verified April 2012 - Condition: Alzheimer's Disease
Interventions: Drug: VI-1121; Drug: Placebo
Sponsors: VIVUS, Inc.; VIVUS, Inc.; Medpace, Inc.
Recruiting - verified April 2012 - Condition: Alzheimer's Disease
Interventions: Drug: MABT5102A; Drug: MABT5102A; Drug: placebo; Drug: placebo
Sponsors: Genentech; Genentech
Recruiting - verified April 2012 - Condition: Alzheimer's Disease
Intervention:
Sponsors: Columbia University; Columbia University; National Institute on Aging (NIA)
Recruiting - verified August 2011 - Condition: Dementia Alzheimer's Type
Interventions: Drug: SAR110894D; Drug: placebo
Sponsors: Sanofi-Aventis; Sanofi-Aventis
Recruiting - verified May 2012 - Conditions: Mild Cognitive Impairment (MCI); Alzheimer's Disease
Intervention:
Sponsors: Alzheimer's Disease Cooperative Study (ADCS); Alzheimer's Disease Cooperative Study (ADCS); Northern California Institute for Research and Education (NCIRE); National Institute on Aging (NIA)
Recruiting - verified May 2012 - Condition: Alzheimer Disease
Interventions: Drug: gantenerumab; Drug: gantenerumab; Drug: placebo
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified May 2012 - Condition: Late Onset Alzheimer Disease
Intervention: Drug: BAY 94-9172 (Florbetaben)
Sponsors: New York State Psychiatric Institute; Yaakov Stern; Bayer; National Institute on Aging (NIA)
Recruiting - verified January 2012 - Condition: Alzheimer's Disease
Intervention: Drug: Solanezumab
Sponsors: Eli Lilly and Company; Eli Lilly and Company
Recruiting - verified May 2012 - Conditions: Mild Cognitive Impairment; Alzheimer's Disease
Intervention:
Sponsors: Alzheimer's Disease Cooperative Study (ADCS); Alzheimer's Disease Cooperative Study (ADCS); Northern California Institute for Research and Education (NCIRE); National Institute on Aging (NIA)
Recruiting - verified February 2012 - Condition: Alzheimer Disease
Intervention: Drug: ACC-001+ QS21
Sponsors: Pfizer; Pfizer; JANSSEN Alzheimer Immunotherapy Research & Development, LLC
Recruiting - verified April 2012 - Condition: Alzheimer's Disease
Intervention: Drug: memantine
Sponsors: New York University School of Medicine; New York University School of Medicine
Recruiting - verified July 2011 - Condition: Alzheimer Disease
Intervention: Drug: bapineuzumab
Sponsors: Pfizer; Pfizer; JANSSEN Alzheimer Immunotherapy Research & Development, LLC
Recruiting - verified March 2012 - Conditions: Alzheimer's Disease; Agitation
Interventions: Drug: citalopram; Drug: placebo
Sponsors: Johns Hopkins University; Johns Hopkins University; National Institute on Aging (NIA); National Institute of Mental Health (NIMH)
Recruiting - verified May 2012 - Condition: Alzheimer's Disease
Interventions: Genetic: CERE-110: Adeno-Associated Virus Delivery of NGF; Procedure: Placebo Surgery
Sponsors: Ceregene; Ceregene; Alzheimer's Disease Cooperative Study (ADCS)
Recruiting - verified May 2012 - Condition: Alzheimer's Disease
Intervention:
Sponsors: Washington University School of Medicine; Washington University School of Medicine; National Institute on Aging (NIA)
Recruiting - verified October 2011 - Conditions: Alzheimer's Disease; Aphasia; Language Difficulties; Dementia
Intervention: Device: Repetitive Transcranial Magnetic Coil Stimulation (rTMS)
Sponsors: The New York Memory Services; The New York Memory Services
Recruiting - verified July 2011 - Condition: Alzheimer Disease
Interventions: Drug: bapineuzumab; Drug: bapineuzumab; Drug: placebo
Sponsors: Pfizer; Pfizer
Recruiting - verified April 2012 - Condition: Dementia
Intervention: Procedure: FDG-PET brain scan
Sponsors: University of California, Los Angeles; University of California, Los Angeles; Centers for Medicare and Medicaid Services
Recruiting - verified April 2012
 |
Join Clinical Trials in New York for Alzheimers Disease |
